ABO blood group is related to the prevalence, severity, and mortality rate of COVID-19
Authors:
- Mehran KouchekMKMehran Kouchek
- Mir Mohammad MiriMMMir Mohammad Miri
- Kamran AghakhaniKAKamran Aghakhani
- Azadeh MemarianAMAzadeh Memarian
Open Access
- 13 April 2024
- journal article
- research article
- Published by Elsevier in Medicina Clínica Práctica
- Vol. 7 (3)
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Pediatric and adolescent COVID‐19 vaccination side effects: A retrospective cohort study of the Iranian teenage group in 2021Journal of Medical Virology, 2022
- Immunologic response, Efficacy, and Safety of Vaccines against COVID-19 Infection in Healthy and immunosuppressed Children and Adolescents Aged 2 – 21 years old: A Systematic Review and Meta-analysisJournal of Clinical Virology, 2022
- ABO blood groups and the risk of SARS-CoV-2 infectionProtoplasma, 2022
- ABO blood groups and risk of human immunodeficiency virus infection: A systematic review and meta‐analysisReviews in Medical Virology, 2021
- Evaluation of ABO blood group in subjects with CVD risk factors in a population sample from northeastern IranDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020
- Investigating Whether Blood Type Is Linked to COVID-19 RiskJAMA, 2020
- Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysisJournal of Infection, 2020
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorCell, 2020
- ABO blood group, hepatitis B viral infection and risk of pancreatic cancerInternational Journal of Cancer, 2011
- ABO Blood Group and Susceptibility to Severe Acute Respiratory SyndromeJAMA, 2005